Drugs / RESOLVIN E1
RESOLVIN E1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00941018 | Jun → Sep 2009 | — | Resolvyx Pharmaceuticals, Inc | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RESOLVIN E1 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1742483 ↗ |
| Known as | J2.218.407E | ChEMBL registry synonym — accepted as the source's own label CHEMBL1742483 ↗ |
| Known as | RX-10001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00941018 ↗ |
| Modality | Small molecule | — CHEMBL1742483 ↗ |
| Route | Oral | “administered as an oral solution” NCT00941018 ↗ |